{
  "emaEpar": [],
  "fdaDrugLabel": [
    {
      "brand": "Picato",
      "indication": "1 INDICATIONS AND USAGE Picato \u00ae gel is indicated for the topical treatment of actinic keratosis. Picato gel is an inducer of cell death indicated for the topical treatment of actinic keratosis. ( 1 )",
      "manufacturer": "LEO Pharma Inc.",
      "splSetId": "5accc7a5-8209-4680-b0ae-2a6963500419"
    }
  ],
  "id": "Ingenol_Mebutate",
  "nciThesaurus": {
    "casRegistry": "75567-37-2",
    "chebiId": "",
    "chemicalFormula": "C25H34O6",
    "definition": "A selective small-molecule activator of protein kinase C (PKC) isolated from the plant Euphorbia peplus with potential antineoplastic activity. Ingenol mebutate activates various protein kinase C (PKC) isoforms, thereby inducing apoptosis in some tumor cells, including myeloid leukemia cells, melanoma cells, and basal cell carcinoma cells. The PKC family consists of signaling isoenzymes that regulate many cell processes including proliferation, differentiation, and apoptosis.",
    "fdaUniiCode": "7686S50JAH",
    "identifier": "C48398",
    "preferredName": "Ingenol Mebutate",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C274"
    ],
    "synonyms": [
      "2-Butenoic acid, 2-methyl-, (1aR,2S,5R,5aS,6S,8aS,9R,10aR)-1a,2,5,5a,6,9,10,10a- octahydro-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1H-2,8a- methanocyclopenta[a]cyclopropa[e]cyclodecen-6-yl ester, (2Z)-",
      "I3A",
      "INGENOL MEBUTATE",
      "Ingenol Mebutate",
      "Ingenol-3-angelate",
      "PEP-005",
      "PEP005"
    ]
  }
}